Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15163423rdf:typepubmed:Citationlld:pubmed
pubmed-article:15163423lifeskim:mentionsumls-concept:C0019369lld:lifeskim
pubmed-article:15163423lifeskim:mentionsumls-concept:C0019351lld:lifeskim
pubmed-article:15163423lifeskim:mentionsumls-concept:C1440693lld:lifeskim
pubmed-article:15163423lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:15163423lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15163423lifeskim:mentionsumls-concept:C0005767lld:lifeskim
pubmed-article:15163423lifeskim:mentionsumls-concept:C0022688lld:lifeskim
pubmed-article:15163423lifeskim:mentionsumls-concept:C0026985lld:lifeskim
pubmed-article:15163423lifeskim:mentionsumls-concept:C1956385lld:lifeskim
pubmed-article:15163423lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:15163423pubmed:issue4lld:pubmed
pubmed-article:15163423pubmed:dateCreated2004-5-27lld:pubmed
pubmed-article:15163423pubmed:abstractTextHow the immune system contains herpes simplex virus (HSV) infections is partly understood. T cells from infected persons proliferate in response to HSV antigens in vitro and may control local relapse rather than primary infection. NK cells have been involved in the control of experimental infections. A potentially important, as yet unexplored, population of interest might be the plasmacytoid dendritic cells (PDC), which contrary to monocytes, produce very high amounts of the major antiviral molecules, type-I interferon (IFN) following interaction with HSV.lld:pubmed
pubmed-article:15163423pubmed:languageenglld:pubmed
pubmed-article:15163423pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15163423pubmed:citationSubsetIMlld:pubmed
pubmed-article:15163423pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15163423pubmed:statusMEDLINElld:pubmed
pubmed-article:15163423pubmed:monthAuglld:pubmed
pubmed-article:15163423pubmed:issn1386-6532lld:pubmed
pubmed-article:15163423pubmed:authorpubmed-author:DalloulAliAlld:pubmed
pubmed-article:15163423pubmed:authorpubmed-author:RibaudPatrici...lld:pubmed
pubmed-article:15163423pubmed:authorpubmed-author:ChosidowOlivi...lld:pubmed
pubmed-article:15163423pubmed:authorpubmed-author:AutranBrigitt...lld:pubmed
pubmed-article:15163423pubmed:authorpubmed-author:OksenhendlerE...lld:pubmed
pubmed-article:15163423pubmed:authorpubmed-author:MassipPatrice...lld:pubmed
pubmed-article:15163423pubmed:authorpubmed-author:LebonPierrePlld:pubmed
pubmed-article:15163423pubmed:authorpubmed-author:CarcelainGuyl...lld:pubmed
pubmed-article:15163423pubmed:authorpubmed-author:LouvetSylvieSlld:pubmed
pubmed-article:15163423pubmed:issnTypePrintlld:pubmed
pubmed-article:15163423pubmed:volume30lld:pubmed
pubmed-article:15163423pubmed:ownerNLMlld:pubmed
pubmed-article:15163423pubmed:authorsCompleteYlld:pubmed
pubmed-article:15163423pubmed:pagination329-36lld:pubmed
pubmed-article:15163423pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:15163423pubmed:meshHeadingpubmed-meshheading:15163423...lld:pubmed
pubmed-article:15163423pubmed:meshHeadingpubmed-meshheading:15163423...lld:pubmed
pubmed-article:15163423pubmed:meshHeadingpubmed-meshheading:15163423...lld:pubmed
pubmed-article:15163423pubmed:meshHeadingpubmed-meshheading:15163423...lld:pubmed
pubmed-article:15163423pubmed:meshHeadingpubmed-meshheading:15163423...lld:pubmed
pubmed-article:15163423pubmed:meshHeadingpubmed-meshheading:15163423...lld:pubmed
pubmed-article:15163423pubmed:meshHeadingpubmed-meshheading:15163423...lld:pubmed
pubmed-article:15163423pubmed:meshHeadingpubmed-meshheading:15163423...lld:pubmed
pubmed-article:15163423pubmed:meshHeadingpubmed-meshheading:15163423...lld:pubmed
pubmed-article:15163423pubmed:meshHeadingpubmed-meshheading:15163423...lld:pubmed
pubmed-article:15163423pubmed:meshHeadingpubmed-meshheading:15163423...lld:pubmed
pubmed-article:15163423pubmed:meshHeadingpubmed-meshheading:15163423...lld:pubmed
pubmed-article:15163423pubmed:year2004lld:pubmed
pubmed-article:15163423pubmed:articleTitleSevere herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood.lld:pubmed
pubmed-article:15163423pubmed:affiliationLaboratoire d'Imunologie Hôpital de la Pitié, Paris, France. ali.dalloul@inserm.ipsc.u-psud.frlld:pubmed
pubmed-article:15163423pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15163423pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15163423lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15163423lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15163423lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15163423lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15163423lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15163423lld:pubmed